DOI: 10.1055/s-00022861

Aktuelle Kardiologie


Haude M, Ince H, Abizaid A. et al.
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.

Lancet 2016;
387: 31-39

Download Bibliographical Data

Search in: